NAC supplementation could improve lung function in patients with acute exacerbation of chronic obstructive pulmonary disease

The investigators found in a review article of 12 retrospective analyses and 3 randomized controlled trials (RCTs) with 1,605 patients, that n-acetylcysteine (NAC) supplementation could promote the symptom improvement rate of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), improve lung function in FEV1 and FEV1/FVC and enhance the body’s antioxidant capacity.

Read more right here:
NAC supplementation could improve lung function in patients with acute exacerbation of chronic obstructive pulmonary disease